Literature DB >> 31302218

Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents.

Laura Ghirardi1, Henrik Larsson2, Zheng Chang3, Qi Chen3, Patrick D Quinn4, Kwan Hur5, Robert D Gibbons5, Brian M D'Onofrio6.   

Abstract

OBJECTIVE: Our objective was to determine whether attention-deficit/hyperactivity disorder (ADHD) medication is associated with a decreased risk of unintentional injuries in children and adolescents in the United States across sexes, age groups and injury types.
METHOD: We used de-identified inpatient, outpatient, and filled prescription claims data from the Truven Health MarketScan Research Databases. Individuals were followed from January 1, 2005, date of first ADHD diagnosis, or medication prescription, or age 6 years, whichever occurred last, until December 31, 2014, first healthcare insurance disenrollment, or the first year at which their age was recorded as 19 years, whichever occurred first. A person was considered on ADHD medication during a given month if a prescription was filled in that month. The outcome was defined as emergency department visits for injuries, including traumatic brain injuries, with unintentional causes. Odds of having the outcome were compared between medicated and unmedicated months at the population-level and in within-individual analyses using logistic regression.
RESULTS: Among 1,968,146 individuals diagnosed with ADHD or receiving ADHD medication, 87,154 had at least one event. At the population level, medication use was associated with a lower risk of injuries, both in boys (odds ratio [OR] = 0.85; 95% CI = 0.84-0.86) and girls (OR = 0.87; 95% CI = 0.85-0.89). Similar results were obtained from within-individual analysis among male (OR = 0.72; 95% CI = 0.70-0.74) and female (OR = 0.72; 95% CI = 0.69-0.75) children, and among male (OR = 0.64; 95% CI = 0.60-0.67) and female (OR = 0.65; 95% CI = 0.60-0.71) adolescents. Similar results were found for traumatic brain injuries.
CONCLUSION: ADHD medication use was associated with a reduction of different types of unintentional injuries in children and adolescents of both sexes.
Copyright © 2019 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  attention-deficit disorder with hyperactivity/drug therapy

Mesh:

Substances:

Year:  2019        PMID: 31302218      PMCID: PMC6954332          DOI: 10.1016/j.jaac.2019.06.010

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  29 in total

1.  Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012.

Authors:  Christian J Bachmann; Linda P Wijlaars; Luuk J Kalverdijk; Mehmet Burcu; Gerd Glaeske; Catharina C M Schuiling-Veninga; Falk Hoffmann; Lise Aagaard; Julie M Zito
Journal:  Eur Neuropsychopharmacol       Date:  2017-03-20       Impact factor: 4.600

Review 2.  Attention-deficit/hyperactivity disorder and adverse health outcomes.

Authors:  Joel T Nigg
Journal:  Clin Psychol Rev       Date:  2012-12-07

3.  ADHD Medication and Substance-Related Problems.

Authors:  Patrick D Quinn; Zheng Chang; Kwan Hur; Robert D Gibbons; Benjamin B Lahey; Martin E Rickert; Arvid Sjölander; Paul Lichtenstein; Henrik Larsson; Brian M D'Onofrio
Journal:  Am J Psychiatry       Date:  2017-06-29       Impact factor: 18.112

4.  Association Between Prescription of Major Psychotropic Medications and Violent Reoffending After Prison Release.

Authors:  Zheng Chang; Paul Lichtenstein; Niklas Långström; Henrik Larsson; Seena Fazel
Journal:  JAMA       Date:  2016-11-01       Impact factor: 56.272

Review 5.  ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis.

Authors:  Guilherme V Polanczyk; Erik G Willcutt; Giovanni A Salum; Christian Kieling; Luis A Rohde
Journal:  Int J Epidemiol       Date:  2014-01-24       Impact factor: 7.196

6.  Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study.

Authors:  Zheng Chang; Paul Lichtenstein; Brian M D'Onofrio; Arvid Sjölander; Henrik Larsson
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

7.  Association between ADHD drug use and injuries among children and adolescents.

Authors:  Els van den Ban; Patrick Souverein; Willemijn Meijer; Herman van Engeland; Hanna Swaab; Toine Egberts; Eibert Heerdink
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-06-04       Impact factor: 4.785

8.  Methylphenidate and the risk of trauma.

Authors:  Kenneth K C Man; Esther W Chan; David Coghill; Ian Douglas; Patrick Ip; Ling-Pong Leung; Matthew S H Tsui; Wilfred H S Wong; Ian C K Wong
Journal:  Pediatrics       Date:  2014-12-15       Impact factor: 7.124

9.  The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study.

Authors:  Christina Lindemann; Ingo Langner; Tobias Banaschewski; Edeltraut Garbe; Rafael T Mikolajczyk
Journal:  Front Pediatr       Date:  2017-10-24       Impact factor: 3.418

10.  Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016.

Authors:  Guifeng Xu; Lane Strathearn; Buyun Liu; Binrang Yang; Wei Bao
Journal:  JAMA Netw Open       Date:  2018-08-03
View more
  2 in total

1.  Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders.

Authors:  Laura Ghirardi; Qi Chen; Zheng Chang; Ralf Kuja-Halkola; Charlotte Skoglund; Patrick D Quinn; Brian M D'Onofrio; Henrik Larsson
Journal:  J Child Psychol Psychiatry       Date:  2019-10-18       Impact factor: 8.982

2.  Risk of Respiratory Infectious Diseases and the Role of Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder: A Population-Based Cohort Study.

Authors:  Dian-Jeng Li; Yi-Lung Chen; Ray C Hsiao; Hsiu-Lin Chen; Cheng-Fang Yen
Journal:  Int J Environ Res Public Health       Date:  2021-05-28       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.